Peter Lang

Peter Lang currently serves as the Chief Financial Officer at Opthea, where responsibilities include leading financial strategy and capital financing for pivotal Phase 3 trials targeting wet AMD. Lang has a robust history in finance and investment banking, having held senior roles at companies such as Aerie Pharmaceuticals and Ridge Advisory LLC, where strategic repositioning and capital allocation were key focuses. Experience as a Managing Director at HSBC and FBR & Co. includes leading healthcare investment banking efforts while developing client relationships with biopharma companies. Lang's educational background includes an MBA from The University of Chicago Booth School of Business and dual bachelor's degrees from the University of Pennsylvania and The Wharton School, enhancing expertise in entrepreneurial finance and strategic management.